Results 101 to 110 of about 1,458,916 (304)

Comparing outcomes using low‐dose apixaban and anti‐Xa monitoring and vitamin K antagonists in patients with renal replacement therapy

British Journal of Clinical Pharmacology, EarlyView.
Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou, Alexander T. Cohen, Lucy Vernon, Victoria Collings, Ubonphan Chaichana, Natasha Moore, Hamda Jibril, Li Wei, Nicola Kumar, Karen A. Breen, Andrew J. Doyle   +10 more
wiley   +1 more source

Oral surgery in patients on anticoagulants without therapy interruption

, 2006
Purpose: Conflicting opinions exist in literature concerning the management of oral surgery in patients on oral anticoagulants, since no consensus on perioperative protocols or guidelines on therapy modification or withdrawal are available.
D. Carmagnola, G. Pastori, S. Castiglioni, S. Abati, G. Ferrieri   +4 more
core   +2 more sources

Harnessing blood clot as a native scaffold for orchestrating tissue repairs and regeneration

BMEMat, EarlyView.
The blood clot, owing to its dynamic composition and unique microenvironment, holds significant yet underappreciated potential for tissue engineering. This review systematically summarizes the pathophysiology of clot formation, the key regulatory factors shaping its microenvironment, and its applications in both pre‐clinical and clinical settings ...
Gao‐peng Dang, Yu‐zhu Wang, Yi‐fei Wang, Que Bai, Jia‐xin Hao, Zhi‐ting Li, Xiao‐qing Cao, Yu Wei, Yue Feng, Ji‐hua Chen, Franklin R. Tay, Rui‐bing Wang, Jun‐ting Gu, Li‐na Niu   +13 more
wiley   +1 more source

Efficacy and safety of novel oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolism

Bangladesh Journal of Pharmacology, 2018
The aim of this meta-analysis was to systematically evaluate the efficacy and safety of novel oral anticoagulants and vitamin K antagonists in the treatment of venous thromboembolism.
Maodi Xu, Qingquan Xue, Zhichen Pu, Zijing Wu, Haitang Xie   +4 more
doaj   +1 more source

Satisfaction with oral anticoagulants in patients with atrial fibrillation [PDF]

, 2018
Carmen Suárez Fernández,1 Luis Castilla-Guerra,2 Jesus Cantero Hinojosa,3 Josep Maria Suriñach,4 Fernando Acosta de Bilbao,5 Juan José Tamarit,6 José Luis Diaz Diaz,7 Jose Luis Hernandez,8 Antonio Pose,9 Manuel Montero ...
José Luis Diaz Diaz, Roquer, Jaume, Suriñach, Josep Maria, Suárez Fernández C, Suriñach JM, Pose A, Mostaza, José María, Gállego, Jaime, Jose Maria Mostaza, Hernández, Jose Luis, Josep Maria Suriñach, Suárez Fernández, Carmen, Antonio Pose, Acosta de Bilbao, Fernando, Montero-Pérez-Barquero, Manuel, Castilla-Guerra, Luis, Hernández Hernández, José Luis, Hernandez JL, Mostaza JM, Cantero Hinojosa, Jesus, Carmen Suárez Fernández, José Vivancos, Pose, Antonio, Vivancos, José, Vivancos J, Luis Castilla-Guerra, Jaime Gállego, Jesus Cantero-Hinojosa, Jose Luis Hernandez, Jaume Roquer, Tamarit JJ, Roquer J, Fernando Acosta de Bilbao, Manuel Montero-Pérez-Barquero, Gállego J, Tamarit, Juan José, Diaz Diaz, José Luis, Montero-Pérez-Barquero M, Diaz Diaz JL, Juan José Tamarit, Cantero Hinojosa J, Castilla-Guerra L, Acosta de Bilbao F   +42 more
core   +1 more source

Management of severe bone loss in patients at risk of medication‐related osteonecrosis of the jaw with microsurgery and guided bone regeneration: A case study

Clinical Advances in Periodontics, EarlyView.
Abstract Background Medication‐related osteonecrosis of the jaw (MRONJ) is a challenging complication associated with antiresorptive medications. Its exact pathophysiology remains unclear, but dental extractions and infections are known triggers, complicating prevention, and treatment.
Pedro Franco Ferreira, José Maurício Paradella de Camargo, Lara Maria Alencar Ramos Innocentini, Ana Carolina Fragoso Motta   +3 more
wiley   +1 more source

Impact of prior oral anticoagulation on admission stroke severity in patients with atrial fibrillation

Biomedical Papers
Background and Aims. In patients with atrial fibrillation, oral anticoagulation therapy is indicated for both primary and secondary prevention of stroke/systemic embolism.
David Franc, Daniel Sanak, Michal Kral, Martin Hutyra, Milos Taborsky, Petra Divisova, Jana Zapletalova   +6 more
doaj   +1 more source

Evaluation of Treatment Response of Calcified Nodules and Nodular Calcified Lesions Using Mean Density on Coronary Computed Tomography Angiography

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Calcified nodules (CN) and nodular calcifications (NC) present significant challenges during percutaneous coronary intervention (PCI) because of their protruding morphology and high rigidity, which often result in inadequate stent expansion and suboptimal procedural outcomes.
Akito Setoguchi, Keita Iyama, Ryosuke Iwasaki, Saburo Kusumoto, Yoshiyuki Doi, Tatsuya Nunohiro, Masayoshi Takeno, Koji Maemura   +7 more
wiley   +1 more source

Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants

Clinical Interventions in Aging, 2015
Mohit K Turagam, Poonam Velagapudi, Greg C FlakerDivision of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia, MO, USAAbstract: Stroke prevention in elderly atrial fibrillation patients remains a challenge.
Turagam MK, Velagapudi P, Flaker GC
doaj  

Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease

Рациональная фармакотерапия в кардиологии, 2019
The purpose of this review is to examine the possibilities and prospects for the use of direct oral anticoagulants for the prevention of thromboembolic complications in patients with atrial fibrillation and chronic kidney disease.
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko   +3 more
doaj   +1 more source